ikervis
santen oy - ciclosporin - hornhinde sygdomme - oftalmologiske - behandling af alvorlig keratitis hos voksne patienter med øje med tør øjne, som ikke er forbedret på trods af behandling med tyresubstitutter.
testogel 16,2 mg/g transdermal gel
laboratoires besins int. s.a.s. - testosteron - transdermal gel - 16,2 mg/g
testim 50 mg/dosis transdermal gel
endo ventures limited (ireland) - testosteron - transdermal gel - 50 mg/dosis
testogel 50 mg/dosis transdermal gel
laboratoires besins int. s.a.s. - testosteron - transdermal gel - 50 mg/dosis
testavan 20 mg/g transdermal gel
the simple pharma company limited - testosteron - transdermal gel - 20 mg/g
testogel 50 mg/dosis transdermal gel
orifarm a/s - testosteron - transdermal gel - 50 mg/dosis
testavan 20 mg/g transdermal gel
2care4 aps - testosteron - transdermal gel - 20 mg/g
protopic
leo pharma a/s - tacrolimus - dermatitis, atopisk - andre dermatologiske præparater - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. der forekommer fire eller flere gange om året), der har haft en indledende reaktion på højst seks uger behandling af to gange dagligt tacrolimus salve (læsioner ryddet, næsten ryddet eller let påvirket).
adtralza
leo pharma a/s - tralokinumab - dermatitis, atopisk - andre dermatologiske præparater - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
staquis
pfizer europe ma eeig - crisaborole - dermatitis, atopisk - andre dermatologiske præparater - staquis er indiceret til behandling af mild til moderat atopisk dermatitis hos voksne og pædiatriske patienter fra 2 år med ≤ 40% legemsoverflade (bsa), der berøres.